Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115699) titled 'Research on Sleep Brainwave Blood Sugar Control Technology' on Dec. 30, 2025.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: The First Affiliated Hospital of Xinxiang Medical University
Condition:
The blood sugar and sleep structure of people with type 2 diabetes
Intervention:
The AB sequence group (the "first phase ACLS then phase ACLS" group):Phase-aligned ACLS followed by phase-opposed ACLS
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: The AB sequence group (the "first phase ACLS then phase ACLS" group):10;BA seq...